These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3894895)

  • 101. Creutzfeldt-Jakob disease after pituitary gonadotrophins.
    Healy DL; Evans J
    BMJ; 1993 Aug; 307(6903):517-8. PubMed ID: 8400968
    [No Abstract]   [Full Text] [Related]  

  • 102. Creutzfeldt-Jakob legacy for Australian women treated with human pituitary gonadotropins.
    Dumble LJ; Klein RD
    Lancet; 1992 Oct; 340(8823):847-8. PubMed ID: 1357261
    [No Abstract]   [Full Text] [Related]  

  • 103. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case.
    Cochius JI; Hyman N; Esiri MM
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1094-5. PubMed ID: 1469410
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Suspension of the Australian human pituitary hormone programme.
    Lazarus L
    Med J Aust; 1985 Jul; 143(2):57-9. PubMed ID: 3894895
    [No Abstract]   [Full Text] [Related]  

  • 105. [Pituitary dwarfism--progress of therapy].
    Suwa S
    Nihon Rinsho; 1986 Mar; 44(3):703-10. PubMed ID: 3090312
    [No Abstract]   [Full Text] [Related]  

  • 106. Clinical review 58: Creutzfeldt-Jakob disease in recipients of pituitary hormones.
    Frasier SD; Foley TP
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1277-9. PubMed ID: 8200924
    [No Abstract]   [Full Text] [Related]  

  • 107. Creutzfeldt-Jakob disease following treatment with human pituitary hormones.
    Preece MA
    Clin Endocrinol (Oxf); 1991 Jun; 34(6):527-9. PubMed ID: 1889134
    [No Abstract]   [Full Text] [Related]  

  • 108. [Treatment of children with short stature with human growth hormone and its potential risks].
    Sizonenko PC
    Arch Fr Pediatr; 1993 May; 50(5):369-74. PubMed ID: 8239885
    [No Abstract]   [Full Text] [Related]  

  • 109. Transmission of Creutzfeldt-Jakob disease by investigative and therapeutic procedures.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1991; 10(2):89-98. PubMed ID: 1932464
    [No Abstract]   [Full Text] [Related]  

  • 110. The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases.
    Brown P
    Ciba Found Symp; 1988; 135():3-23. PubMed ID: 3044708
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Iatrogenic transmission of Creutzfeldt-Jakob disease.
    Weller RO
    Psychol Med; 1989 Feb; 19(1):1-4. PubMed ID: 2657828
    [No Abstract]   [Full Text] [Related]  

  • 112. Human pituitary growth hormone and Creutzfeldt-Jakob disease.
    Preece M
    Horm Res; 1993; 39(3-4):95-8. PubMed ID: 8262483
    [No Abstract]   [Full Text] [Related]  

  • 113.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.